Product
Treatment as Usual plus lisdexamfetamine plus Contingency Management
1 clinical trial
4 indications
Indication
Methamphetamine AbuseIndication
Methamphetamine dependenceIndication
Substance Use DisorderIndication
SubstanceClinical trial
Addition of High Dose Stimulant and Engagement-focused Contingency Management (CM), Alone and in Combination, to Treatment as Usual (TAU) for the Management of Methamphetamine (MA) Use Disorder (ASCME): a Canadian Multi-centre, RCTStatus: Recruiting, Estimated PCD: 2025-11-01